TATEO, VALENTINA
 Distribuzione geografica
Continente #
EU - Europa 153
NA - Nord America 145
AS - Asia 85
AF - Africa 15
Totale 398
Nazione #
US - Stati Uniti d'America 145
IT - Italia 58
SG - Singapore 37
CN - Cina 26
SE - Svezia 16
BG - Bulgaria 14
DE - Germania 13
CH - Svizzera 12
GB - Regno Unito 10
IN - India 9
CI - Costa d'Avorio 8
IE - Irlanda 8
FI - Finlandia 7
NL - Olanda 7
ID - Indonesia 6
JO - Giordania 4
TG - Togo 4
NG - Nigeria 3
AT - Austria 2
MY - Malesia 2
RU - Federazione Russa 2
UA - Ucraina 2
JP - Giappone 1
MD - Moldavia 1
PL - Polonia 1
Totale 398
Città #
Singapore 34
Bologna 18
Chandler 16
Sofia 14
Ashburn 13
Bern 12
Milan 10
Turin 9
Abidjan 8
Dublin 8
Santa Clara 7
Jakarta 6
New York 6
Princeton 6
Helsinki 5
Hyderabad 5
Southend 5
Amman 4
Lomé 4
Redmond 4
Rimini 4
Abeokuta 3
Cologne 3
Columbus 3
Houston 3
Seattle 3
Woodbridge 3
Amsterdam 2
Beijing 2
Berlin 2
Breda 2
Florence 2
Guangzhou 2
Lappeenranta 2
Legnano 2
Los Angeles 2
Moscow 2
Munich 2
Nanjing 2
San Diego 2
Seri Kembangan 2
Slough 2
Utrecht 2
Vienna 2
Wilmington 2
Boardman 1
Cambridge 1
Chengdu 1
Chisinau 1
Enschede 1
Fairfield 1
Fuzhou 1
Hangzhou 1
Jinan 1
Leicester 1
Modena 1
Prescot 1
Qingdao 1
Shanghai 1
Shijiazhuang 1
Southwark 1
Taizhou 1
Tokyo 1
Warsaw 1
Wenzhou 1
Yueqing 1
Totale 273
Nome #
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors 64
Hacking pancreatic cancer: Present and future of personalized medicine 58
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances 53
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis 37
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 37
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 28
Tumor growth rate to assess therapy response to immune-based combinations for metastatic renal cell carcinoma 23
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics 21
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study 21
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 19
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 19
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study 15
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? 14
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital Tumours 13
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma 11
Totale 433
Categoria #
all - tutte 2.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 3 4 0 0 3
2021/202241 0 0 1 0 3 1 0 8 5 3 15 5
2022/2023124 6 8 8 7 9 6 3 4 20 6 26 21
2023/2024147 10 11 13 17 19 32 0 18 3 9 9 6
2024/2025111 27 39 30 15 0 0 0 0 0 0 0 0
Totale 433